Manufacturing Round-Up: Sterling Gains A US Site As Normon Invests €100m

Sterling Pharma Solutions has acquired a US facility and Olon has bought a plant from Sandoz, while Normon is investing €100m in manufacturing expansions.

Work station
• Source: Shutterstock

UK-based contract development and manufacturing organization (CDMO) Sterling Pharma Solutions has acquired CiVentiChem’s US facility in Cary, North Carolina. This “will allow Sterling to offer a local presence to its US clients and enhance its chemistry development capabilities to support pre-clinical and early-phase clinical supply”. Sterling’s CEO, Kevin Cook, said “we have been keen to expand our presence in the US market and the site’s capabilities complement our current service offering,” noting that the North American market accounted for “70% of our customer portfolio.”

Italian active pharmaceutical ingredient (API) specialist Olon has closed its acquisition of a former Sandoz manufacturing facility in Mahad,...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business